E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/25/2006 in the Prospect News Biotech Daily.

N Spine's devices achieve milestones; company completes financing

By Lisa Kerner

Charlotte, N.C., Sept. 25 - N Spine, Inc. announced the first clinical use of its NFlex Posterior Dynamic Stabilization System, facility certification and CE Mark approval of its NFlex Dynamic Stabilization and NFix Fusion Systems, enrollment in a controlled study and the closing of a series B round of financing.

The privately held San Diego medical-device company's lead product, NFlex, is a titanium pedicle screw system for the spine that will be studied in comparison to Zimmer Spine's Dynesys.

N Spine's NFix System is Food and Drug Administration-approved use in skeletally mature patients as an adjunct to fusion.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.